【0】Hexachlorophene (United States: Not available): Drug information

【1】Contributor Disclosures

【2】For abbreviations, symbols, and age group definitions show table

【3】Pharmacologic Category

【4】*   Antibiotic, Topical

【5】Dosing: Adult

【6】All products have been discontinued for more than 1 year.

【7】Dosing: Older Adult

【8】Refer to adult dosing.

【9】Dosing: Pediatric

【10】Refer to adult dosing.

【11】Adverse Reactions

【12】The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.

【13】<1%, postmarketing, and/or case reports: Dermatitis, erythema, irritability, neurologic injury, seizure, skin photosensitivity, xeroderma

【14】Contraindications

【15】Hypersensitivity to halogenated phenol derivatives or hexachlorophene; use on burned or denuded skin; use as an occlusive dressing, wetpack, or lotion; application to mucous membranes; use as a vaginal pack or tampon; routine use for prophylactic total body bathing

【16】Warnings/Precautions

【17】**_Concerns related to adverse effects:_**

【18】• Cerebral irritability: Discontinue use if signs of cerebral irritability occur.

【19】**_Special populations:_**

【20】• Burn patients: Exposure to patients with extensive burns has been associated with apnea, convulsions, agitation and coma.

【21】• Pediatric: Exposure to preterm infants has been associated with apnea, convulsions, agitation and coma; particularly susceptible to hexachlorophene topical absorption. Do not use for bathing infants.

【22】**_Other warnings/precautions:_**

【23】• Appropriate use: For external use only; avoid exposure to eyes.

【24】Warnings: Additional Pediatric Considerations

【25】Premature and low birth weight neonates are particularly susceptible to hexachlorophene topical absorption; irritability, generalized clonic muscular contractions, decerebrate rigidity, and brain lesions in the white matter have occurred in infants following topical use of 6% hexachlorophene; exposure of preterm infants or patients with extensive burns has been associated with apnea, convulsions, agitation, and coma.

【26】Product Availability

【27】All products have been discontinued for more than 1 year.

【28】Generic Equivalent Available: US

【29】Pricing: US

【30】**Liquid** (Phisohex External)

【31】3% : $61.26

【32】**Disclaimer:** The pricing data provided represent a median AWP and/or AAWP price for the brand and/or generic product, respectively. The pricing data should be used for benchmarking purposes only, and as such should not be used to set or adjudicate any prices for charging or reimbursement functions. Pricing data is updated monthly.

【33】Hazardous Drugs Handling Considerations

【34】Hazardous agent; use appropriate precautions for handling and disposal (EPA, U-listed).

【35】Use: Labeled Indications

【36】Surgical scrub and as a bacteriostatic skin cleanser; control an outbreak of gram-positive infection when other procedures have been unsuccessful

【37】Medication Safety Issues

【38】Sound-alike/look-alike issues:

【39】pHisoHex may be confused with Fostex, pHisoDerm

【40】Pediatric patients: High-risk medication:

【41】KIDs List: Hexachlorophene, when used in neonates, is identified on the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) list and should be avoided due to risk of neurotoxicity (strong recommendation; high quality of evidence) (PPA \[Meyers 2020\]).

【42】Metabolism/Transport Effects

【43】None known.

【44】Drug Interactions  

【45】There are no known significant interactions.

【46】Pregnancy Considerations

【47】Adverse events have been observed in animal reproduction studies. Hexachlorophene is absorbed systemically when applied topically. Following use as an antiseptic for vaginal exams during labor, hexachlorophene is detectable in the maternal serum and cord blood (Strickland, 1983). Vaginal use as a pack or tampon and application to mucous membranes is contraindicated.

【48】Breastfeeding Considerations

【49】It is not known if hexachlorophene is excreted in breast milk. Due to the potential for serious adverse reactions in the nursing infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother.

【50】Mechanism of Action

【51】Bacteriostatic polychlorinated biphenyl which inhibits membrane-bound enzymes and disrupts the cell membrane

【52】Pharmacokinetics (Adult Data Unless Noted)

【53】Absorption: Percutaneously through inflamed, excoriated, and intact skin

【54】Half-life elimination: Infants: 6.1-44.2 hours

【55】Brand Names: International

【56】International Brand Names by Country

【57】For country code abbreviations ( show table )  

【58】*   (AR) Argentina : Sodorant ;
*   (ID) Indonesia : Dermisan ;
*   (NL) Netherlands : Unicura ;
*   (TW) Taiwan : PHisoHex王磊

====================================================================================================
